Pages that link to "Q28282922"
Jump to navigation
Jump to search
The following pages link to Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism (Q28282922):
Displaying 50 items.
- Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome (Q21133920) (← links)
- The genetic basis of addictive disorders (Q24607129) (← links)
- Towards medication-enhancement of cognitive interventions in schizophrenia (Q26860777) (← links)
- COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review (Q28074860) (← links)
- Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition (Q28580165) (← links)
- Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma (Q28728111) (← links)
- Prepulse inhibition predicts spatial working memory performance in the inbred Roman high- and low-avoidance rats and in genetically heterogeneous NIH-HS rats: relevance for studying pre-attentive and cognitive anomalies in schizophrenia (Q30403344) (← links)
- Generation and characterization of humanized mice carrying COMT158 Met/Val alleles (Q30407994) (← links)
- Both the COMT Val158Met single-nucleotide polymorphism and sex-dependent differences influence response inhibition (Q30409993) (← links)
- Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome (Q30435819) (← links)
- Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains (Q30439281) (← links)
- Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults (Q30439296) (← links)
- The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. (Q30450055) (← links)
- Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease (Q30458053) (← links)
- ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex (Q30458759) (← links)
- Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders (Q30459497) (← links)
- Are we studying and treating schizophrenia correctly? (Q30465313) (← links)
- The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. (Q30466238) (← links)
- The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers (Q30471555) (← links)
- Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study (Q30473381) (← links)
- Age-associated improvements in cross-modal prepulse inhibition in mice (Q30475551) (← links)
- Prepulse inhibition and genetic mouse models of schizophrenia (Q30478270) (← links)
- Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (Q30489404) (← links)
- Catechol-O-methyltransferase val158met genotype determines effect of reboxetine on emotional memory in healthy male volunteers (Q33390612) (← links)
- Living in the moment: effects of time perspective and emotional valence of episodic thinking on delay discounting (Q33726490) (← links)
- COMT Val158Met Polymorphism Modulates Cognitive Effects of Dietary Intervention (Q34343510) (← links)
- Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions (Q34685248) (← links)
- Catechol-O-methyltransferase Val158Met polymorphism modulates gray matter volume and functional connectivity of the default mode network (Q35023618) (← links)
- Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood (Q35097990) (← links)
- Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics (Q35282570) (← links)
- COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition (Q35859549) (← links)
- COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokers (Q35887978) (← links)
- Catechol-O-methyltransferase (COMT) influences the connectivity of the prefrontal cortex at rest. (Q36593363) (← links)
- The relationship between dopamine receptor D1 and cognitive performance (Q36848267) (← links)
- The relationship between risk-taking propensity and the COMT Val(158)Met polymorphism among early adolescents as a function of sex. (Q36942330) (← links)
- Possible association between common variants of the phenylalanine hydroxylase (PAH) gene and memory performance in healthy adults (Q37071145) (← links)
- Genotype-Dependent Effects of COMT Inhibition on Cognitive Function in a Highly Specific, Novel Mouse Model of Altered COMT Activity (Q37402659) (← links)
- A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback (Q37472701) (← links)
- Pharmacological cognitive enhancement in schizophrenia (Q37511870) (← links)
- Neurocognitive functioning and genetic variation in patients with primary brain tumours (Q37561807) (← links)
- Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study (Q37650592) (← links)
- Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry (Q37700556) (← links)
- Genetic polymorphisms influence recovery from traumatic brain injury (Q37991924) (← links)
- Genetic polymorphisms and traumatic brain injury: the contribution of individual differences to recovery (Q38033463) (← links)
- Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets (Q38187948) (← links)
- Genetics and the placebo effect: the placebome (Q38425277) (← links)
- Sensorimotor gating in healthy adults tested over a 15 year period (Q39061709) (← links)
- Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates (Q41777494) (← links)
- Double dissociation of dopamine genes and timing in humans (Q43513506) (← links)
- Functional connectivity in healthy subjects is nonlinearly modulated by the COMT and DRD2 polymorphisms in a functional system-dependent manner. (Q45782081) (← links)